Latest News

Preclinical data support remyelinating potential of ABX-002

May 24, 2022 | Research

ABX-002, an experimental treatment for multiple sclerosis (MS) being developed by Autobahn Therapeutics, promoted the restoration of the myelin sheath in preclinical models of the disease, new data show. The research, which specifically tested an analog of ABX-002 called LL-341070, will be presented […]

Funding opportunity

May 10, 2022 | Funding, Research, Study, Training

MSNZ is delighted with the announcement from the New Zealand MS Research Trust that they have received funding of NZ$150,000 a year for three years to support neurologists who wish to travel overseas to specialise in the treatment of people […]

Evaluating health literacy in individuals with a neurological condition and caregivers

December 22, 2021 | Education, Research, Study

Are you living with a neurological condition? Do you support someone living with a neurological condition? Are you interested in undertaking a survey on health and e-health literacy (the ability to find, understand, and use online and offline health information)? […]

Neurology Research Review

December 9, 2021 | Education, Research

The latest edition of Neurology Research Review is out now and has a special focus on MS. Neurology_Research_Review_Issue_77

Recording available – Progressive MS Treatment and Research

June 29, 2021 | Education, Event, Life with MS, Progressive, Research, Treatments

Learn about the latest advances in progressive MS research and treatment during this 30-minute International Progressive MS Alliance webcast. An international panel of MS experts will answer questions submitted by people affected by MS from throughout the world. From symptom […]